Mera Pharmaceuticals, Inc. (MRPI)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Mera Pharmaceuticals Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2011 | 0.0725M |
| July 31, 2011 | 0.00 |
| April 30, 2011 | 0.00 |
| January 31, 2011 | 0.00 |
| October 31, 2010 | 0.00 |
| July 31, 2010 | 0.00 |
| April 30, 2010 | 0.00 |
| January 31, 2010 | 0.00 |
| October 31, 2009 | 0.00 |
| July 31, 2009 | 0.00 |
| April 30, 2009 | 0.00 |
| January 31, 2009 | 0.00 |
| October 31, 2008 | 0.1344M |
| July 31, 2008 | -0.0114M |
| April 30, 2008 | 0.0123M |
| January 31, 2008 | 0.0243M |
| October 31, 2007 | -0.012M |
| July 31, 2007 | -0.008M |
| April 30, 2007 | -0.019M |
| January 31, 2007 | 0.099M |
| October 31, 2006 | 0.0025M |
| July 31, 2006 | 0.0975M |
| April 30, 2006 | 0.00 |
| January 31, 2006 | 0.138M |
| October 31, 2005 | 0.036M |
| Date | Value |
|---|---|
| July 31, 2005 | 0.15M |
| April 30, 2005 | 0.182M |
| January 31, 2005 | 0.1956M |
| October 31, 2004 | 0.0169M |
| July 31, 2004 | -0.10M |
| April 30, 2004 | -0.0092M |
| January 31, 2004 | 1.359M |
| October 31, 2003 | 0.0298M |
| July 31, 2003 | 0.116M |
| April 30, 2003 | 0.052M |
| January 31, 2003 | 0.925M |
| October 31, 2002 | -2.00M |
| July 31, 2002 | 1.85M |
| April 30, 2002 | 0.25M |
| January 31, 2002 | 0.25M |
| October 31, 2001 | 0.3521M |
| July 31, 2001 | 0.75M |
| April 30, 2001 | 0.9625M |
| January 31, 2001 | 0.7792M |
| October 31, 2000 | 1.312M |
| July 31, 2000 | 0.4559M |
| April 30, 2000 | 1.512M |
| January 31, 2000 | 0.735M |
| October 31, 1999 | 0.943M |
| July 31, 1999 | 0.8539M |
Cash From Financing Definition
Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -0.449M |
| Oncolytics Biotech, Inc. | 6.704M |
| Sangamo Therapeutics, Inc. | 26.70M |
| Sarepta Therapeutics, Inc. | 0.00 |
| Anixa Biosciences, Inc. | 1.936M |